MASSACHUSETTS GENERAL HOSPITAL
Harnessing the soluble guanylate cyclase pathway to alleviate early life RSV bronchiolitis
Harnessing the soluble guanylate cyclase pathway to alleviate early life RSV bronchiolitis is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 364484, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
Project Summary: Respiratory Syncytial Virus (RSV) infection is the most common cause of hospitalization in young children, leading to respiratory failure and even death in severe cases. Viral bronchiolitis with airflow obstruction is the cardinal pathophysiology of RSV infection in early life. Unfortunately,…